Aid-In-Dying: Not So Easy
In June, California will become the fifth state to allow terminally ill patients to end their lives with prescriptions from their doctors, but getting those prescriptions will require serious effort.
Drug Costs
681-700 of 707 results
-
-
More Exchange Plans Offer Patients Easier Access To Some Expensive Drugs: Report
The analysis by Avalere examines changes in how silver plans on the insurance marketplaces handle coverage for high-cost specialty drugs.
-
What’s California’s Prescription For Rising Drug Costs?
How high-cost drugs are impacting California.
-
By Not Discussing Cost Issues, Doctors, Patients May Miss Chances To Lower Out-Of-Pocket Expenses
A study published in Health Affairs examines how physician-patient interactions often present missed opportunities to control patients’ health care spending.
-
Mortgages For Expensive Health Care? Some Experts Think It Can Work.
An MIT economist and Harvard oncologist propose offering loans to patients to cover the cost of expensive, curative drugs, financed by private sector investment in loan securities.
-
Pharmaceutical Company Has Hiked Price On Aid-In-Dying Drug
Valeant Pharmaceuticals, the company that makes Seconal, the drug most commonly used in prescribed for terminally ill patients who want to end their lives, physician-assisted suicide, has doubled the price to more than $3,000.
-
Coinsurance Trend Means Seniors Likely To Face Higher Out-Of-Pocket Drug Costs, Report Says
More Medicare Part D drug plans are requiring coinsurance rather than copayments for more types of medications, making beneficiaries’ costs less predictable.
-
How Medicare Drug Plans Hope To Follow Private Sector Lead
The proposal that Medicare made this month to better control prescription drug costs involves testing strategies used with some success in the private sector.
-
N.H., Calif. Seek To Help Consumers Get Details On Health Care Prices
New Hampshire is expanding its website that lists the cost of specific medical procedures to include dental treatments and 65 prescription drugs. California is expanding its report cards on large medical groups to include cost of medical services by an average patient.
By Jordan Rau -
Medicare To Test New Payment Approaches For Some Prescription Medications
Regulators unveiled a two-part plan that will change payments and test ways in which the Medicare Part B program can change the incentives that some policy experts say encourage doctors to choose higher-cost medications.
-
Candidates’ Drug-Price Plans May Miss The Mark
There is more than one reason prices are rising, and no single solution.
By Julie Rovner -
Urban Medicare Beneficiaries May See More Drug Savings This YearÂ
The Centers for Medicare & Medicaid Services says access to special, lower-cost pharmacies has improved for Medicare beneficiaries in urban areas.
-
Are States Obligated To Provide Expensive Hepatitis C Drugs?
New hepatitis C drugs boast cure rates of at least 95 percent. But states are restricting their use for Medicaid patients and prisoners because the cost is so high.
-
Study: Doctors’ Texts Can Prod Patients To Take Drugs, But Questions Linger
In an analysis published Monday in JAMA Internal Medicine, researchers found that text message reminders help patients do better when it comes to taking their medicines. But questions about the specific ways to make the most of this strategy remain.
-
California Voters Will Have Their Say On Drug Prices
Heated battle expected over November ballot proposal to curb state’s prescription drug costs, as pharmaceutical industry opens its pocketbook to defeat the measure.
By Anna Gorman -
Want Into A Clinical Trial? Read This First. Â
Experimental drugs might help desperate patients, but don’t count on an easy cure.
By Emily Bazar -
Health Plans’ Coverage Of Some Drugs Can Be A Source Of Consumer Confusion
Some medicines, particularly intravenous treatments, are not listed in plans’ pharmacy benefit section and, therefore, it’s difficult to confirm coverage specifics.
-
Testing For Hepatitis C In Prisons Could Save Many Lives On The Outside
Treating Hep C is expensive, but new drugs can quickly cure the disease, ultimately saving money.
-
Cancer Meds Often Bring Big Out-Of-Pocket Costs For Patients, Report Finds
The advocacy arm of the American Cancer Society said Wednesday that federal and state governments should move to restrict insurers from charging patients a percentage of the cost of their prescription drugs.
-
Study Finds Marketplace Silver Plans Offer Poor Access To HIV Drugs
Only 16 percent of the popular plans cover all 10 of the most common drug regimens and charge less than $100 a month in consumer cost sharing, according to a report by Avalere Health.